A third dose of Pfizer’s Covid vaccine significantly improves protection from infection and serious illness among people aged 60 and older, findings published by the Health Ministry in Israel showed on Sunday.
The data were presented at a meeting of a ministry panel of vaccination experts on Thursday and uploaded to its website on Sunday, though the full details of the study were not released.
The findings were on par with separate statistics reported last week by Israel's Maccabi healthcare provider, one of several organisations administering booster shots to try to curb the Delta coronavirus variant.
Israel started administering third jabs to over 60-year-olds on July 30. The UK is yet to announce whether it will have a programme of booster shots.
It comes as antibody tests will be available to the public in the UK for the first time, from Tuesday. Those getting a PCR test will be able to have the option of checking for antibodies.
